BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv7.32.0//EN
X-ORIGINAL-URL:https://www.yorku.ca/science/chemistry/
X-WR-CALNAME:Department of Chemistry
X-WR-CALDESC:Department of Chemistry
X-WR-TIMEZONE:America/Toronto
BEGIN:VTIMEZONE
TZID:America/Toronto
X-LIC-LOCATION:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T030000
RRULE:FREQ=YEARLY;BYMONTH=03;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T010000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-eaa52f3366768bca401dca9ea5b181dd@yorku.ca
DTSTART;TZID=America/Toronto:20240308T133000
DTEND;TZID=America/Toronto:20240308T143000
DTSTAMP:20240301T162155Z
CREATED:20240301
LAST-MODIFIED:20240415
PRIORITY:5
SEQUENCE:2
TRANSP:OPAQUE
SUMMARY:Seminar series - Anthony Rullo
DESCRIPTION:Title: Covalent "Proximity-Induction" Strategies to Modulate Ligand-Receptor Interactions for Immunoncology\nAbstract: A major class of tumor immunotherapeutics function by bridging immune machinery with tumor antigens, highly expressed on cancer cells compared to normal tissue. Antibody recruiting molecules represent an emerging synthetic immunotherapeutic strategy to bridge serum antibodies with these tumor antigens, leading to Fc receptor mediated anti-tumor function. In this seminar, we describe the development of a new medicinal chemistry strategy that uses covalent chimeric molecules, to enhance antibody recruitment to cancer cells. The covalent engagement of serum antibodies affects unique anti-tumor functional enhancements, generating new hypotheses surrounding mechanisms of immune receptor activation. More generally, covalency may represent a strategic tool to modulate the kinetics of immune receptor interactions directly, without intermediary antibodies. This has special utility for mechanistic interrogation of receptor pharmacology and the development of novel covalent tumor immunotherapeutic drugs and targeting strategies.\n\n
URL:https://www.yorku.ca/science/chemistry/events-old/seminar-series-anthony-rullo/
LOCATION:Petrie Science and Engineering Building Room 317 (PSE 317)
END:VEVENT
END:VCALENDAR
